参考文献/References:
[1] YANG D,OPPENHEIM JJ.Antimicrobial proteins act as“alarmins” in joint immune defense[J].Arthritis Rheum,2004,50(11):3401-3403.
[2] JANEWAY CA.The immune system evolved to discriminate infectious nonself from noninfectious self[J].Immunol Today,1992,13(1):11-16.
[3] TOUBAI T,MATHEWSON ND,MAGENAU J,REDDY P.Danger signals and graft-versus-host disease:current understanding and future perspectives[J].Front Immunol,2016,7:539.
[4] CZURA CJ,WANG H,TRACEY KJ.Dual roles for HMGB1:DNA binding and cytokine[J].J Endotoxin Res,2001,7(4):315-321.
[5] CAO MQ,ZHOU HY,ZHANG T.Research progress of alarmins[J].Int J Immunol,2014,37(1):35-39.
曹曼卿,周洪渊,张倜.警报素家族研究进展[J].国际免疫学杂志,2014,37(1):35-39.
[6] NIE Y,YANG D,OPPENHEIM JJ.Alarmins and antitumor immunity[J].Clin Ther,2016,38(5):1042-1053.
[7] NEMETH BC,VARKONYI T,SOMOGYVARI F,LENGYEL C,FEHERTEMPLOMI K,NYIRATY S,et al.Relevance of α-defensins (HNP1-3) and defensin β-1 in diabetes[J].World J Gastroenterol,2014,20(27):9128-9137.
[8] XIAO Q,GAO QP.Research advances of HMGB1 to lymphocytes[J].Chin J Immunol,2015,31(5):715-718.
肖茜,高清平.HMGB1对淋巴细胞作用的研究进展[J].中国免疫学杂志,2015,31(5):715-718.
[9] LAUDET V,STEHELIN D,CLEVERS H.Ancestry and diversity of the HMG box superfamily[J].Nucleic Acids Res,1993,21(10):2493-2501.
[10] PARK JS,ARCAROLI J,YUM HK,YANG H,WANG H,YANG KY,et al.Activation of gene expression in human neutrophils by high mobility group box 1 protein[J].Am J Physiol Cell Physiol,2003,284(4):C870-C879.
[11] LAMKANFI M,SARKAR A,VANDE WALLE L,VITARI AC,AMER AO,WEWERS MD,et al.Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia[J].J Immunol,2010,185(7):4385-4392.
[12] BELL CW,JIANG W,REICH CF,PISETSKY DS.The extracellular release of HMGB1 during apoptotic cell death[J].Am J Physiol Cell Physiol,2006,291(6):C1318-C1325.
[13] SCAFFIDI P,MISTELI T,BIANCHI ME.Release of chromatin protein HMGB1 by necrotic cells triggers inflammation[J].Nature,2002,418(6894):191-195.
[14] HAN SJ,MIN HJ,YOON SC,KO EA,PARK SJ,YOON JH,et al.HMGB1 in the pathogenesis of ultraviolet-induced ocular surface inflammation[J].Cell Death Dis,2015,6:e1863.
[15] QIN S,WANG H,YUAN R,LI H,OCHANI M,OCHANI K,et al.Role of HMGB1 in apoptosis-mediated sepsis lethality[J].J Exp Med,2006,203(7):1637-1642.
[16] LI XJ,YE QF,WANG YF,LI L,LIU QW.Hgh mobility group B1:the target of ischemia reperfusion injury of liver[J].Natl Med J Chin,2014,94(10):793-796.
李晓璟,叶啟发,王彦峰,李玲,刘倩雯.高迁移率族蛋白B1:肝脏缺血再灌注损伤中的重要靶点[J].中华医学杂志,2014,94(10):793-796.
[17] ARIMURA N,KII Y,HASHIGUCHI T,KAWAHARA K,BISWAS KK,NAKAMURA M,et al.Intraocular expression and release of high-mobility group box 1 protein in retinal detachment[J].Lab Invest,2009,89(3):278-289.
[18] PACHYDAKI SI,TARI SR,LEE SE,MA W,TSENG JJ,SOSUNOV AA,et al.Upregulation of RAGE and its ligands in proliferative retinal disease[J].Exp Eye Res,2006,82(5):807-815.
[19] LIN Q,YANG XP,FANG D,REN X,ZOU H,FANG J,et al.High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis[J].Arterioscler Thromb Vasc Biol,2011,31(5):1024-1032.
[20] MCCLELLAN S,JIANG X,BARRETT R,HAZLETT LD.High-mobility group box 1:a novel target for treatment of Pseudomonas aeruginosa keratitis[J].J Immunol,2015,194(4):1776-1787.
[21] MCDERMOTT AM.The role of antimicrobial peptides at the ocular surface[J].Ophthalmic Res,2009,41(2):60-75.
[22] ABEDIN A,MOHAMMED I,HOPKINSON A,DUA HS.A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection[J].Invest Ophthalmol Vis Sci,2008,49(1):28-33.
[23] GU ZS,SHENG YH.Progress in the study of human defensins in ophthalmology[J].Chin J Optom Ophthalmol,2007,9(6):428-431.
辜臻晟,盛耀华.人类防御素在眼科的研究进展[J].眼视光学杂志,2007,9(6):428-431.
[24] IKEDA A,SAKIMOTO T,SHOJI J,SAWA M.Expression of alpha- and beta-defensins in human ocular surface tissue[J].Jpn J Ophthalmol,2005,49(2):73-78.
[25] DAN J,YANG YN,SONG XS.Distribution of human beta defensins in ocular and its expression in ocular surface disease[J].Chin J Optom Ophthalmol Vis Sci,2014,16(4):253-256.
但婧,杨燕宁,宋秀胜.人类β-防御素在眼部的分布及眼表疾病中的表达[J].中华眼视光学与视觉科学杂志,2014,16(4):253-256.
[26] MCINTOSH RS,CADE JE,AL-ABED M,SHANMUGANATHAN V,GUPTA R,BHAN A,et al.The spectrum of antimicrobial peptide expression at the ocular surface[J].Invest Ophthalmol Vis Sci,2005,46(4):1379-1385.
[27] OTRI AM,MOHAMMED I,AL-AQABA MA,FARES U,PENG C,HOPKINSON A,et al.Variable expression of human Beta defensins 3 and 9 at the human ocular surface in infectious keratitis[J].Invest Ophthalmol Vis Sci,2012,53(2):757-761.
[28] HUA X,YUAN X,TANG X,LI Z,PFLUGFELDER SC,LI DQ.Human corneal epithelial cells produce antimicrobial peptides LL-37 and β-defensins in response to heat-killed Candida albicans[J].Ophthalmic Res,2014,51(4):179-186.
[29] MOHAMMED I,SULEMAN H,OTRI AM,KULKARNI BB,CHEN P,HOPKINSON A,et al.Localization and gene expression of human beta-defensin 9 at the human ocular surface epithelium[J].Invest Ophthalmol Vis Sci,2010,51(9):4677-4682.
[30] WU M,MCCLELLAN SA,BARRETT RP,ZHANG Y,HAZLETT LD.Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis[J].J Immunol,2009,183(12):8054-8060.
[31] AUGUSTIN DK,HEIMER SR,TAM C,LI WY,LE DUE JM,EVANS DJ,et al.Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal[J].Infect Immun,2011,79(2):595-605.
[32] ROY S,MARLA S,PRANEETHA DC.Recognition of corynebacterium pseudodiphtheriticum by Toll-like receptors and up-regulation of antimicrobial peptides in human corneal epithelial cells[J].Virulence,2015,6(7):716-721.
[33] OTRI AM,MOHAMMED I,ABEDIN A,CAO Z,HOPKINSON A,PANJWANI N,et al.Antimicrobial peptides expression by ocular surface cells in response to Acanthamoeba castellanii:an in vitro study[J].Br J Ophthalmol, 2010,94(11):1523-1527.
[34] MELONI M,DE SERVI B,MARASCO D,DEL PRETE S.Molecular mechanism of ocular surface damage:application to an in vitro dry eye model on human corneal epithelium[J].Mol Vis,2011,17:113-126.
[35] REDFERN RL,PATEL N,HANION S,FARLEY W,GONDO M,PFLUGFELDER SC,et al.Toll-like receptor expression and activation in mice with experimental dry eye[J].Invest Ophthalmol Vis Sci,2013,54(2):1554-1563.
[36] TU HL,BA T,LIU LY.Research on the antibacterial repair effect and mechanism of Cathelicidin LL-37[J].Chin J Inj Rep Wound Heal (Electr Edit),2015,10(6):523-526.
屠华雷,巴特,刘玲英.Cathelicidin LL-37抗菌修复作用及机制的研究进展[J].中华损伤与修复杂志:电子版,2015,10(6):523-526.
[37] MA N,WU RY.Research of Cathelicidin LL-37 on the infection of ocular surface and injury repair[J].Int Rev Ophthalmol,2009,33(6):367-371.
马宁,吴仁毅.人抗微生物肽LL-37在眼表感染和创伤修复中的作用研究进展[J].国际眼科纵览,2009,33(6):367-371.
[38] YANG D,ROSENBERG HF,CHEN Q,DYER KD,KUROSAKA K,OPPENHEIM JJ.Eosinophil-derived neurotoxin (EDN),an antimicrobial protein with chemotactic activities for dendritic cells[J].Blood,2003,102(9):3396-3403.
[39] PELIKAN Z.Inflammatory mediator profiles in tears accompanying keratoconjunctival responses induced by nasal allergy[J].Br J Ophthalmol,2013,97(7):820-828.
[40] LIN J,ZHANG L,ZHAO G,SU Z,DENG R,PFLUGFELDER SC,et al.A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium[J].PLoS One,2013,8(4):e60963.
[41] KATO A,SCHLEIMER RP.Beyond inflammation:airway epithelial cells are at the interface of innate and adaptive immunity[J].Curr Opin Immunol,2007,19(6):711-720.
[42] MATSUDA A,OKAYAMA Y,TERAI N,YOKOI N,EBIHARA N,TANIOKA H,et al.The role of interleukin-33 in chronic allergic conjunctivitis[J].Invest Ophthalmol Vis Sci,2009,50(10):4646-4652.
[43] HAZLETT LD,MCCLELLAN SA,BARRETT RP,HUANG X,ZHANG Y,WU M,et al.IL-33 shifts macrophage polarization,promoting resistance against Pseudomonas aeruginosa keratitis[J].Invest Ophthalmol Vis Sci,2010,51(3):1524-1532.
[44] ZHANG L,LU R,ZHAO G,PFLUGFELDER SC,LI DQ.TLR-mediated induction of pro-allergic cytokine IL-33 in ocular mucosal epithelium[J].Int J Biochem Cell Biol,2011,43(9):1383-1391.
[45] RIAU AK,WONG TT,BEUERMAN RW,TONG L.Calcium-binding S100 protein expression in pterygium[J].Mol Vis,2009,15:335-342.
[46] ZHAO Q,XU L,BAI BX.S100A8 and S100A9 in dermatoses[J].Int J Dermatol,2015,41(5):335-338.
赵倩,徐蕾,柏冰雪.S100A8和S100A9在皮肤病的研究进展[J].国际皮肤性病学杂志,2015,41(5):335-338.
[47] DENG Q,SUN M,YANG K,ZHU M,CHEN K,YUAN J,et al.MRP8/14 enhances corneal susceptibility to Pseudomonas aeruginosa Infection by amplifying inflammatory responses[J].Invest Ophthalmol Vis Sci,2013,54(2):1227-1234.
相似文献/References:
[1]柴广睿,刘姝,陈晓隆.核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎症体在眼科疾病中的研究进展[J].眼科新进展,2018,38(9):892.[doi:10.13389/j.cnki.rao.2018.0211]
CHAI Guang-Rui,LIU Shu,CHEN Xiao-Long.The progress of NLRP3 inflammasome in ophthalmic diseases[J].Recent Advances in Ophthalmology,2018,38(1):892.[doi:10.13389/j.cnki.rao.2018.0211]
[2]周永莹,孟凡兰,王婷,等.甘草甜素对角膜上皮损伤愈合中炎症反应的抑制作用[J].眼科新进展,2019,39(11):1024.[doi:10.13389/j.cnki.rao.2019.0234]
ZHOU Yong-Ying,MENG Fan-Lan,WANG Ting,et al.Inhibition of glycyrrhizin on inflammatory response in corneal epithelial wound healing[J].Recent Advances in Ophthalmology,2019,39(1):1024.[doi:10.13389/j.cnki.rao.2019.0234]